Richard Ducray

784 citations

17 papers · 559 · h-index 13

Impact in

Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
- Synthesis and Catalytic Reactions
- Synthesis and Reactivity of Heterocycles
Toxicology top 10%

Papers in

Organic Chemistry 12
- Quinazolinone synthesis and applications 4
- Synthesis and Catalytic Reactions 3
- Synthetic Organic Chemistry Methods 2
Oncology 5
- HER2/EGFR in Cancer Research 3

Co-authors: Marco A. Ciufolini (3 shared papers)Akiyuki Hamasaki (1 shared paper)Dale L. Boger (1 shared paper)Bernard Barlaam (6 shared papers)Jason G. Kettle (3 shared papers)Peter Ballard (3 shared papers)Iain Simpson (3 shared papers)Donald Ogilvie (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)Tetrahedron Letters (2 papers)Angewandte Chemie International Edition (1 paper)
Partner nations: France United Kingdom United States

In The Last Decade

Richard Ducray

17 papers receiving 546 citations

Peers

Countries citing papers authored by Richard Ducray

Since Specialization

Citations

This map shows the geographic impact of Richard Ducray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Ducray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Ducray more than expected).

Fields of papers citing papers by Richard Ducray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Ducray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Ducray. The network helps show where Richard Ducray may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Ducray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Ducray Line = papers co-authored together Richard Ducray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Two Novel 1,2,4,5-Tetrazines that Participate in Inverse Electron Demand Diels−Alder Reactions with an Unexpected Regioselectivity The Journal of Organic Chemistry ·Akiyuki Hamasaki, Richard Ducray, Dale L. Boger	2005	76
2	Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Peter Ballard, Bernard Barlaam, Mark Hickinson, Jason G. Kettle, Donald Ogilvie, Catherine B. Trigwell	2007	70
3	Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase Journal of Medicinal Chemistry ·Sébastien L. Degorce, Bernard Barlaam, Elaine Cadogan, Allan Dishington, Richard Ducray, Steven C. Glossop, Lorraine Hassall, Franck Lach, Alan Lau, Thomas M. McGuire, Thorsten Nowak, Gilles Ouvry, Kurt G. Pike, Andrew Thomason	2016	56
4	Tris(trifluoromethanesulfonyl)methide (“Triflide”) Anion: Convenient Preparation, X-ray Crystal Structures, and Exceptional Catalytic Activity as a Counterion with Ytterbium(III) and Scandium(III) The Journal of Organic Chemistry ·Francis J. Waller, Anthony G. M. Barrett, D. Christopher Braddock, Dorai Ramprasad, R. Murray McKinnell, Andrew J. P. White, David J. Williams, Richard Ducray	1999	54
5	Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Iain Simpson, Frédéric Jung, J. Willem M. Nissink, Peter W. Kenny, Martina Fitzek, Graeme E. Walker, Lara Ward, Kevin Hudson	2011	44
6	Total Synthesis of (±)‐FR66979 Angewandte Chemie International Edition ·Richard Ducray, Marco A. Ciufolini	2002	39
7	Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators Journal of Medicinal Chemistry ·Sébastien L. Degorce, Andrew Bailey, Rowena Callis, Chris De Savi, Richard Ducray, Gillian M. Lamont, Philip A. MacFaul, Mickaël Maudet, Scott Martin, Rémy Morgentin, Richard A. Norman, Aurélien Peru, Jennifer H. Pink, Patrick A. Plé, Bryan Roberts, James S. Scott	2015	37
8	Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: Optimization of the aniline Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Clifford D. Jones, Frédéric Jung, Iain Simpson, Jon Curwen, Martin Pass	2011	36
9	Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Catherine Bardelle, Bernard Barlaam, Nigel Brooks, Tanya Coleman, Darren A.E. Cross, Richard Ducray, Isabelle Green, Christine Lambert‐van der Brempt, Annie Olivier, Jon Read	2010	30
10	Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Richard Ducray, Christine Lambert‐van der Brempt, Patrick A. Plé, Catherine Bardelle, Nigel Brooks, Tanya Coleman, Darren A.E. Cross, Jason G. Kettle, Jon Read	2011	26
11	Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R) Journal of Medicinal Chemistry ·Sébastien L. Degorce, Scott Boyd, Jon Curwen, Richard Ducray, Christopher T. Halsall, Clifford D. Jones, Franck Lach, Eva M. Lenz, Martin Pass, Sarah L. Pass, Catherine B. Trigwell	2016	24
12	A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, Peter Ballard, Robert H. Bradbury, Richard Ducray, Hervé Germain, D. Mark Hickinson, Kevin Hudson, Jason G. Kettle, Teresa Klinowska, Françoise Magnien, Donald Ogilvie, Annie Olivier, Stuart E. Pearson, James S. Scott, Abid Suleman, Cath Trigwell, Michel Vautier, Robin Whittaker, Robin Wood	2007	18
13	Homo-Brook route to benzazocenols and congeners via allylsilane-derived aziridines Tetrahedron Letters ·Richard Ducray, Nicolai Cramer, Marco A. Ciufolini	2001	12
14	A versatile route to 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridines and 3-(pyrimidin-4-yl)-pyrazolo[1,5-a]pyridines Tetrahedron Letters ·Richard Ducray, Pascal Boutron, Myriam Didelot, Hervé Germain, Franck Lach, Maryannick Lamorlette, Antoine Legriffon, Mickaël Maudet, Morgan Ménard, Georges Pasquet, Fabrice G. Renaud, Iain Simpson, Gail L. Young	2010	12
15	Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam, David Acton, Peter Ballard, Robert H. Bradbury, Darren A.E. Cross, Richard Ducray, Hervé Germain, Kevin Hudson, Teresa Klinowska, Françoise Magnien, Donald Ogilvie, Annie Olivier, Helen S. Ross, Robin Smith, Cath Trigwell, Michel Vautier, Lindsay Wright	2008	10
16	Total Synthesis of (±)‐FR66979 Angewandte Chemie ·Richard Ducray, Marco A. Ciufolini	2002	10
17	ChemInform Abstract: Lanthanoid Triflate and Triflide Catalyzed Atom Economic Nitration of Fluoroarenes. ChemInform ·Anthony G. M. Barrett, D. Christopher Braddock, Richard Ducray, R. Murray McKinnell, Francis J. Waller	2000	5

About Richard Ducray

Richard Ducray is a scholar working on Organic Chemistry, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 17 papers that have together received 559 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (4 papers), HER2/EGFR in Cancer Research (3 papers), Synthesis and Catalytic Reactions (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Axon Guidance and Neuronal Signaling (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Chromatography in Natural Products (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Organic Chemistry (372 citations), Toxicology (19 citations), Oncology (88 citations), Pharmaceutical Science (21 citations) and Molecular Biology (207 citations). Richard Ducray has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Marco A. Ciufolini, Akiyuki Hamasaki, Dale L. Boger, Bernard Barlaam, Jason G. Kettle, Peter Ballard, Iain Simpson, Donald Ogilvie, Frédéric Jung and Clifford D. Jones. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Tetrahedron Letters and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Richard Ducray

Impact in

Papers in i

In The Last Decade

Richard Ducray

Peers

Countries citing papers authored by Richard Ducray

Fields of papers citing papers by Richard Ducray

All Works

About Richard Ducray

Explore authors with similar magnitude of impact

Papers in